Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
973
-
Total 13F shares, excl. options
-
373M
-
Shares change
-
+12.2M
-
Total reported value, excl. options
-
$42.3B
-
Value change
-
+$1.26B
-
Put/Call ratio
-
0.91
-
Number of buys
-
524
-
Number of sells
-
-425
-
Price
-
$113.38
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q2 2024
1,173 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q2 2024.
DEXCOM INC - Common Stock (DXCM) has 973 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 373M shares
of 392M outstanding shares and own 95.3% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (46.5M shares), BlackRock Inc. (34.5M shares), STATE STREET CORP (16.3M shares), BAILLIE GIFFORD & CO (15.3M shares), Capital Research Global Investors (11.9M shares), SANDS CAPITAL MANAGEMENT, LLC (10.6M shares), FMR LLC (9.79M shares), GEODE CAPITAL MANAGEMENT, LLC (9.72M shares), Capital World Investors (8.31M shares), and JPMORGAN CHASE & CO (6.71M shares).
This table shows the top 973 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.